Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1779501014 | Aspirin + oxycodone hydrochloride + oxycodone terephthalate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3490645012 | Product containing aspirin and oxycodone hydrochloride and oxycodone terephthalate (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3494840013 | Product containing aspirin and oxycodone hydrochloride and oxycodone terephthalate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2857571000052111 | acetylsalicylsyra + oxikodonhydroklorid + oxikodontereftalat | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| acetylsalicylsyra + oxikodonhydroklorid + oxikodontereftalat | Is a | oxikodonhydroklorid | false | Inferred relationship | Some | ||
| acetylsalicylsyra + oxikodonhydroklorid + oxikodontereftalat | Is a | kombinationspreparat med acetylsalicylsyra | false | Inferred relationship | Some | ||
| acetylsalicylsyra + oxikodonhydroklorid + oxikodontereftalat | Has active ingredient | Oxycodone hydrochloride (substance) | false | Inferred relationship | Some | ||
| acetylsalicylsyra + oxikodonhydroklorid + oxikodontereftalat | Has active ingredient | Oxycodone terephthalate | false | Inferred relationship | Some | ||
| acetylsalicylsyra + oxikodonhydroklorid + oxikodontereftalat | Has active ingredient | Aspirin (substance) | false | Inferred relationship | Some | ||
| acetylsalicylsyra + oxikodonhydroklorid + oxikodontereftalat | Has active ingredient | Central nervous system agent (substance) | false | Inferred relationship | Some | ||
| acetylsalicylsyra + oxikodonhydroklorid + oxikodontereftalat | Is a | oxikodontereftalat | false | Inferred relationship | Some | ||
| acetylsalicylsyra + oxikodonhydroklorid + oxikodontereftalat | Is a | Product containing aspirin in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| acetylsalicylsyra + oxikodonhydroklorid + oxikodontereftalat | Has manufactured dose form | Oral dose form | false | Inferred relationship | Some | ||
| acetylsalicylsyra + oxikodonhydroklorid + oxikodontereftalat | Is a | Product containing aspirin (medicinal product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely aspirin 325 milligram and oxycodone hydrochloride 2.25 milligram and oxycodone terephthalate 190 microgram/1 each conventional release oral tablet (clinical drug) | Is a | False | acetylsalicylsyra + oxikodonhydroklorid + oxikodontereftalat | Inferred relationship | Some | |
| Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet | Is a | False | acetylsalicylsyra + oxikodonhydroklorid + oxikodontereftalat | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
FHIR